Cipla's USFDA inspects InvaGen facility in New York

Cipla's USFDA inspects InvaGen facility in New York — Cipla has announced a routine update regarding a USFDA inspection at its InvaGen manufacturing facility in Hauppauge, Long Island. The inspection is part of regular regulatory compliance checks. No critical observations or adverse findings have been reported so far.

📊 STOCKS: $CIPLA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Regulatory